ICVBD 2021

Deadline for Abstract submission: October 1, 2021

Contact information (NUS)
R Manjunatha Kini, Professor
 dbskinim@nus.edu.sg

Introduction

Organised by National University of Singapore, Singapore 

Vector-borne diseases such as malaria, dengue, schistosomiasis, human African trypanosomiasis, leishmaniasis, Chagas disease, yellow fever, Japanese encephalitis and onchocerciasis, cause more than 700,000 deaths globally. Mosquitoes, sandflies, blackflies, ticks, tsetse flies, mites and lice transmit the pathogens including parasites, viruses and bacteria that cause these diseases. The major vector-borne diseases account for 17% of all infectious diseases. Tropical and subtropical areas, including Singapore, are disproportionately affected. Recent outbreaks of dengue, malaria, chikungunya, yellow fever and Zika afflicted populations around the globe, claimed lives and overwhelmed health systems. Singapore has an excellent community of scientists focused on various aspects of vector-borne diseases. To encourage and entice participation of the next generation of young scientists to work in this research area, and to find solutions to reduce the burden of vector-borne diseases, we are planning to organize this international conference and bring regional and global leaders together to tackle this threat to global health.   The Conference will serve as a platform for researchers to present their recent research findings as well as to exchange cutting-edge strategies in various aspects of vector-borne diseases. The Scientific Sessions include epidemiology, vector control, vaccination, host-pathogen interactions, vector-pathogen interactions, vector-host interactions, pathogenicity, vector barriers, and vector competence.

Oral presentations

There will be about 20 Oral presentations. The speakers, preferably graduate students, postdoctoral fellows and early career scientists, will be selected to give these oral presentations based on the submitted abstracts.  

Poster presentations

Two or three poster sessions will also be organized. Abstracts will be evaluated for poster presentations.

Deadline for Abstracts: October 1, 2021

PROGRAM SUMMARY – page in progress

Organizing Committee

 R Manjunatha Kini (Chairman), National University of Singapore
 Henry Mok, National University of Singapore
 J Sivaraman, National University of Singapore
 Sylvie Alonso, National University of Singapore
 Subhash Vasudevan, Duke-NUS
 Lisa Ng, SIgN, A*STAR
 Lee Ching Ng, EHI
 Yu Cai, TLL

International Advisory Committee

– George Dimopoulos, Johns Hopkins, USA
– Mariano Garcia-Blanco, UTMB, USA
– Jack Johnson, Scripps Research Institute, USA

– PAGE IN PROGRESS –

Guidelines for abstract layout

The abstract is to be limited to 200 words, excluding names, addresses and email addresses. Please do not include figures. Please use Arial font size 11.

Sample Abstract format

download ABSTRACT TEMPLATE

——————————————————————————————————————-

LOSS OF T-BET CONFERS SURVIVAL ADVANTAGE TO INFLUENZA–BACTERIAL SUPERINFECTION

Jun Zhi Er, Ricky Abdi Gunawan Koean & Jeak Ling Ding

Dept. Biological Sciences, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260.

The transcription factor, T-bet, regulates type 1 inflammatory responses against a range of infections. Here, we demonstrate a previously unaddressed role of T-bet, to influenza virus and bacterial superinfection. Interestingly, we found that T-bet deficiency did not adversely affect the efficacy of viral clearance or recovery compared to wild-type hosts.

Keynote speakers

1. Jeffrey Almond, Oxford University, UK
2. George Dimopoulos, Johns Hopkins University, USA
3. Eva Harris, University of California Berkley, USA
4. Jack Johnson, The Scripps research Institute, USA
5. Lee Ching Ng, Environmental Health Institute, Singapore
6. Eng Eong Ooi, Duke-NUS, Singapore
7. Peter Preiser, Nanyang Technological University, Singapore
8. Cheng-Feng Qin, Academy of Military Medical Sciences, China
9. Cameron Simmons, Monash University, Australia
 

Invited speakers

1. Sylvie Alonso, National University of Singapore, Singapore
2. Ganesh Anand, National University of Singapore, Singapore
3. Zbynek Bozdech, Nanyang Technological University, Singapore
4. Eric Calvo, National Institutes of Health, USA
5. Chun-Hong Chen, National Health Research Institutes, Taiwan
6. Justin Chu, National University of Singapore, Singapore
7. Ramesh Dhiman, National Institute of Malaria Research, Delhi, India
8. Cynthia He, National University of Singapore, Singapore
9. Hirotaka Kanuka, The Jikei University School of Medicine, Tokyo, Japan
10. Paul Macary, National University of Singapore, Singapore
11. Lisa Ng, Singapore Immunology Network, A*STAR, Singapore
12. Fabiano Oliveira, National Institutes of Health, USA
13. Julien Pompon, IRD, CNRS, University of Montpellier, France
14. Subhash Vasudevan, Duke-NUS, Singapore